| Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study R Pylypchuk, S Wells, A Kerr, K Poppe, T Riddell, M Harwood, D Exeter, ... The Lancet 391 (10133), 1897-1907, 2018 | 248 | 2018 |
| The GATE frame: critical appraisal with pictures R Jackson, S Ameratunga, J Broad, J Connor, A Lethaby, G Robb, ... BMJ Evidence-Based Medicine 11 (2), 35-38, 2006 | 216 | 2006 |
| Patients prefer pictures to numbers to express cardiovascular benefit from treatment F Goodyear-Smith, B Arroll, L Chan, R Jackson, S Wells, T Kenealy The Annals of Family Medicine 6 (3), 213-217, 2008 | 122 | 2008 |
| Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice S Wells, S Furness, N Rafter, E Horn, R Whittaker, A Stewart, K Moodabe, ... European Journal of Preventive Cardiology 15 (2), 173-178, 2008 | 115 | 2008 |
| Cohort profile: the PREDICT cardiovascular disease cohort in New Zealand primary care (PREDICT-CVD 19) S Wells, T Riddell, A Kerr, R Pylypchuk, C Chelimo, R Marshall, DJ Exeter, ... International journal of epidemiology 46 (1), 22-22, 2017 | 101 | 2017 |
| Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy V Selak, A Kerr, K Poppe, B Wu, M Harwood, C Grey, R Jackson, S Wells Jama 319 (24), 2507-2520, 2018 | 64 | 2018 |
| IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care V Selak, CR Elley, S Crengle, M Harwood, R Doughty, B Arroll, L Bryant, ... Contemporary clinical trials 32 (6), 909-915, 2011 | 59 | 2011 |
| Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10 T Riddell, S Wells, R Jackson, AW Lee, S Crengle, D Bramley, ... NZ Med J 123 (1309), 50-61, 2010 | 56 | 2010 |
| Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care—PREDICT-CVD–6 J Broad, S Wells, R Marshall, R Jackson British Journal of General Practice 57 (544), 897-903, 2007 | 49 | 2007 |
| Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2) C Grey, R Jackson, S Wells, S Thornley, R Marshall, S Crengle, ... Heart 100 (10), 770-774, 2014 | 42 | 2014 |
| Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes R Jackson, S Wells, A Rodgers Bmj 337, 2008 | 40 | 2008 |
| Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand V Selak, K Poppe, C Grey, S Mehta, J Winter-Smith, R Jackson, S Wells, ... New Zealand Medical Association, 2020 | 37 | 2020 |
| Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study R Pylypchuk, S Wells, A Kerr, K Poppe, M Harwood, S Mehta, C Grey, ... The Lancet 397 (10291), 2264-2274, 2021 | 34 | 2021 |
| Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16 S Mehta, S Wells, C Grey, T Riddell, A Kerr, R Marshall, S Ameratunga, ... European journal of preventive cardiology 21 (2), 192-202, 2014 | 34 | 2014 |
| High level of capture of coronary intervention and associated acute coronary syndromes in the all New Zealand acute coronary syndrome quality improvement cardiac registry and … AJ Kerr, M Lee, Y Jiang, C Grey, S Wells, M Williams, R Jackson, K Poppe The New Zealand Medical Journal (Online) 132 (1492), 19-29, 2019 | 33 | 2019 |
| Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease KK Poppe, RN Doughty, S Wells, D Gentles, H Hemingway, R Jackson, ... Heart 103 (12), 891-892, 2017 | 33 | 2017 |
| QRISK or Framingham for predicting cardiovascular risk? R Jackson, R Marshall, A Kerr, T Riddell, S Wells BMJ 339, 2009 | 33 | 2009 |
| Predicting bleeding risk to guide aspirin use for the primary prevention of cardiovascular disease: a cohort study V Selak, R Jackson, K Poppe, B Wu, M Harwood, C Grey, R Pylypchuk, ... Annals of Internal Medicine 170 (6), 357-368, 2019 | 31 | 2019 |
| Sociodemographic differences in prevalence of diagnosed coronary heart disease in New Zealand estimated from linked national health records S Thornley, WC Chan, S Crengle, T Riddell, S Ameratunga, S Mehta, ... NZ Med J 124 (1334), 21-34, 2011 | 30 | 2011 |
| Ethnicity and revascularisation following acute coronary syndromes: a 5-year cohort study (ANZACS-QI-3) AJ Kerr, A Mustafa, M Lee, S Wells, C Grey, T Riddell, W Harrison Clinical Correspondence, 2014 | 29 | 2014 |
